8th Antibody Industrial Symposium 2020 (AIS2020)
Тезисы до: 04.09.2020
Даты: 23.11.20 — 24.11.20
Область наук: Биологические;
Е-мейл Оргкомитета: firstname.lastname@example.org
Организаторы: LabEx MAbImprove; MabDesign
The AIS2020 is the ideal conference for scientists, industrials, physicians and policy makers to exchange about therapeutic antibodies.
The Scientific committee has set-up an exciting program around this year theme: “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”, with keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.
The next frontier of Ab-based therapeutics for fighting diseases is the production and application of higher-order multispecific Abs or Ab-like molecules, as well as novel cytokine-based biologics or engineered artificial chimeric antigen receptors (CARs). Indeed multispecific Abs and next-generation immunocytokines provide promising platform for the development of novel therapeutic concepts that could facilitate the generation of safer, more effective pharmaceuticals. Re-directing immune cells with engineered CARs is an exciting approach for efficient adoptive cell therapy. AIS2020 will cover the multifaceted mechanisms induced by novel multimer derivatives, cytokine-based products and CARs in different pathophysiological situations. It will also focus on CMC developability (Chemistry Manufacturing Control) and the early clinical development.
The program will allow opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
The Symposium will take place at the “Corum” conference center in Montpellier, close to the train station, providing easy transport connection and accommodations close to the venue.
Веб-сайт конференции: https://aiscongress.com/